You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Venetoclax resistance

Showing 1 - 25 of 8,365
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Venetoclax Resistance Landscape in Chronic Lymphocytic Leukemia

Recruiting
  • Chronic Lymphocytic Leukemia
  • +4 more
    • Bobigny, France
    • +8 more
    Mar 23, 2022

    Chronic Lymphocytic Leukemia, Loss of Chromosome 17p Trial (Ibrutinib, Venetoclax)

    Withdrawn
    • Chronic Lymphocytic Leukemia
    • Loss of Chromosome 17p
    • (no location specified)
    Oct 29, 2021

    Blastoid Variant Mantle Cell Lymphoma, CCND1 Protein Overexpression, CD20 Positive Trial in Houston (Acalabrutinib, Venetoclax)

    Recruiting
    • Blastoid Variant Mantle Cell Lymphoma
    • +8 more
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 5, 2022

    Idiopathic Pulmonary Fibrosis Trial in Birmingham (Venetoclax)

    Not yet recruiting
    • Idiopathic Pulmonary Fibrosis
    • Birmingham, Alabama
      A. Brent Carter
    Aug 3, 2023

    Multiple Myeloma in Relapse, Multiple Myeloma, Refractory Trial (Venetoclax)

    Not yet recruiting
    • Multiple Myeloma in Relapse
    • Multiple Myeloma, Refractory
    • (no location specified)
    Oct 30, 2023

    Acute Myeloid Leukemia Trial in Memphis (Venetoclax, Azacitidine, Cytarabine)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • Memphis, Tennessee
      St. Jude Children's Research Hospital
    Jul 21, 2023

    Acute Myeloid Leukemia Refractory Trial in Lyon (NP137, Azacitidine Injection, Venetoclax)

    Recruiting
    • Acute Myeloid Leukemia Refractory
    • Lyon, France
      Centre Léon Bérard
    Nov 30, 2023

    Mantle Cell Lymphoma Refractory Trial (Ibrutinib, Venetoclax, Navitoclax)

    Not yet recruiting
    • Mantle Cell Lymphoma Refractory
    • (no location specified)
    May 16, 2023

    Hematopoietic and Lymphoid Cell Tumor, Recurrent Acute Biphenotypic Leukemia, Recurrent Acute Myeloid Leukemia Trial in Houston

    Recruiting
    • Hematopoietic and Lymphoid Cell Neoplasm
    • +6 more
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 31, 2022

    Acute Myeloid Leukemia Trial in Nashville (Biopsy of Bone, Cytarabine, Daunorubicin)

    Recruiting
    • Acute Myeloid Leukemia
    • Biospecimen Collection
    • +5 more
    • Buffalo, New York
    • +1 more
    Jan 27, 2023

    Acute Myeloid Leukemia Trial in Houston (Azacitidine, Venetoclax, NK Cells)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • Houston, Texas
      M.D. Anderson Cancer Center
    Apr 17, 2023

    Leukemia, Myeloid, Acute Trial (Cytarabine, Venetoclax, CPX-351)

    Not yet recruiting
    • Leukemia, Myeloid, Acute
    • (no location specified)
    Nov 25, 2022

    Acute Myeloid Leukemia Trial in Houston (Azacitidine, Cladribine, Cytarabine)

    Recruiting
    • Acute Myeloid Leukemia
    • Houston, Texas
      M D Anderson Cancer Center
    Nov 17, 2022

    Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous

    Recruiting
    • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
    • +6 more
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 31, 2022

    AML/MDS, Acute Myeloid Leukemia, MDS Trial (Danvatirsen, Danvatirsen + Venetoclax)

    Not yet recruiting
    • AML/MDS
    • +2 more
    • (no location specified)
    Aug 14, 2023

    Recurrent B Acute Lymphoblastic Leukemia, Recurrent T Acute Lymphoblastic Leukemia, Refractory B Acute Lymphoblastic Leukemia

    Recruiting
    • Recurrent B Acute Lymphoblastic Leukemia
    • +3 more
    • Houston, Texas
      M D Anderson Cancer Center
    Nov 2, 2022

    Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Philadelphia Chromosome Positive, Recurrent Acute Lymphoblastic

    Active, not recruiting
    • Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
    • +6 more
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 2, 2022

    Acute Myeloid Leukemia Trial in Suzhou (CAV Regimen, MEC Regimen)

    Recruiting
    • Acute Myeloid Leukemia
    • CAV Regimen
    • MEC Regimen
    • Suzhou, Jiangsu, China
      The First Affliated Hospital of Soochow University
    Dec 22, 2022

    Secondary Acute Myeloid Leukemia Trial in Nanjing (Venetoclax;Azacitidine;Homoharringtonine)

    Recruiting
    • Secondary Acute Myeloid Leukemia
    • Nanjing, Jiangsu, China
      The First Affiliated Hospital with Nanjing Medical University
    Aug 21, 2022

    DLBCL, High Grade B-Cell Lymphoma Trial in United States (Venetoclax, Rituximab, Etoposide)

    Completed
    • Diffuse Large B-Cell Lymphoma
    • High Grade B-Cell Lymphoma
    • Boston, Massachusetts
    • +5 more
    Aug 23, 2022

    Acute Myeloid Leukemia Trial in United States (Cytarabine, Idarubicin, Daunorubicin)

    Recruiting
    • Acute Myeloid Leukemia
    • Duarte, California
    • +6 more
    Nov 16, 2022

    Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia, Refractory Acute

    Active, not recruiting
    • Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
    • +2 more
    • Columbus, Ohio
    • +2 more
    Aug 10, 2022

    Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Duarte (8-Chloroadenosine,

    Recruiting
    • Acute Myeloid Leukemia
    • +2 more
    • Duarte, California
      City of Hope Medical Center
    Aug 15, 2022

    Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Houston (Decitabine and

    Recruiting
    • Acute Myeloid Leukemia
    • +2 more
    • Decitabine and Cedazuridine
    • +3 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jun 29, 2022

    Acute Myeloid Leukemia Trial in Columbus (Azacitidine, Biopsy, Enasidenib)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Jun 30, 2022